Homocysteine and Alzheimer disease: An intervention study

Nature Reviews Neurology

Volumn 7, Issue 1, 2011, Pages 9-10

  Sachdev, Perminder S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; CYSTATHIONINE; FOLIC ACID; HOMOCYSTEINE; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PYRIDOXINE; VITAMIN B GROUP; VITAMIN B COMPLEX;

ALZHEIMER DISEASE; BRAIN ATROPHY; COGNITION; DEMENTIA; DRUG MEGADOSE; ENZYME ACTIVITY; HUMAN; HYPERHOMOCYSTEINEMIA; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; METABOLISM; NOTE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ALZHEIMER DISEASE; HOMOCYSTEINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN B COMPLEX;

EID: 78651347104     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.195     Document Type: Review

References (10)

1. Faraci, F. M. & Lentz, s. R. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35, 345-347 (2004).
2. Kruman, i. i., et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926 (2000).
3. smith, A. D., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 5, e12244 (2010).
4. Malouf, R. & Grimley evans, J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database of Systematic Reviews, issue 4. Art. No.: CD004514. doi:10.1002/14651858.CD004514.pub2 (2008).
5. Dangour, A. D., et al. B-vitamins and fatty acids in the prevention and treatment of Alzheimers disease and dementia: a systematic review. J. Alzheimers Dis. 22, 205-224 (2010).
6. vogel, T., Dali-Youcef, N., Kaltenbach, G. & Andr, e. Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int. J. Clin. Pract. 63, 1061-1067 (2009).
7. sachdev, P. s., valenzuela, M., wang, X. L., Looi, J. C. & Brodaty, H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58, 1539-1541 (2002).
8. willette, A. A., et al. Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys. Neurobiol. Aging doi:10.1016/j. neurobiolaging.2010.06.003.
9. seshadri, s., et al. Plasma homocysteine as a risk factor for dementia and Alzheimers disease. N. Engl. J. Med. 346, 476-483 (2002).
10. sachdev, P. s. Dementia prevention: the discordance between observational and intervention studies and the search for more evidence. Early Interv. Psychiatry 3, 80-82 (2009).